Rock BioMedical,Inc.

President of Reliance Medical Technology PTE. LTD., Reliance Holding Group AG, and RMT Medical Biotech Group；President & Board Director of RMT-SUPERCELL Japan, with deep international business experience. Have been promoting the development of the global regenerative medicine industry for many years and is committed to the clinical and medical applications of regenerative medicine.

President of Rock BioMedical. Over 20 years in Top 100 US law firms, devising IP strategies for biopharma companies, conducting licensing & IP due diligence, and developing worldwide IP portfolios for publicly listed companies in Taiwan and USA.

CEO & President of Rock BioTherapeutics；Professor Emeritus at Harvard Medical School；Academician in Taiwan；Founder of multiple biotech ventures, including Fuji ImmunoPharmaceuticals, Shionogi BioResearch, Caxton Life Science Partners, TaiMed Biologics, Synta Pharmaceuticals and Sequential Medicine.

SVP, Rock BioMedical；former CSO of AB Biosciences；former Deputy Director of Harvard Gene Therapy Initiative. Over 25 years in Biologics R&D and over 14 years of industry experiences, including venture building, management and leadership, and deal making with Pharma.

Honorary Deputy Chairman of PwC Taiwan；Managing Supervisor of Taiwan Bio-industry Organization；Supervisor of Medical and Pharmaceutical Industry Technology and Development Centre；Member of various review committees for competitions, funding plans, and investment plans, both held by governments and private entities. With over 35 years of experience as a certified public accountant in Taiwan, is well-versed in cross-border finance, tax planning, mergers and acquisitions, corporate spin-offs, corporate governance, industry development, and business strategy. and has successfully assisted numerous biotech and pharmaceutical companies in successfully going public in Taiwan , and also possesses extensive experience in guiding enterprises through cross-border listings.

Former deputy director of the College of Medicine and former Professor in the Department of Biotechnology at I-Shou University. She specializes in drug design and dosage form development, biochips, nanotechnology, pharmacokinetics, and tissue engineering. Holding a Ph.D. in Pharmacy from Kaohsiung Medical University, she possesses a strong academic research background and cross-industry experience, making herself as an influential leader and educator in the biotechnology field.

Brings extensive experience in corporate finance and venture investment. He previously served as Head of the Corporate Banking Division at E.SUN Bank and as a senior executive at E.SUN Financial Holding. He is currently the General Manager of E.SUN Venture Capital and holds board or supervisory positions in several venture investment firms, with a long-standing focus on industry investment and strategic planning.

Specializes in system integration, enterprise resource management, and optimization algorithms, with a strong focus on applying intelligent technologies to the healthcare industry. Under his leadership, his company has become one of the pioneers in digital health solutions. President of EverFortune.AI Co., Ltd. Specializes in system integration, enterprise resource management and optimization algorithms. Brings a unique blend of academic, industrial, and technological expertise to the advancement of smart healthcare.

Has extensive experience in financial research and administration. Associate Professor, Department of Finance and Banking, Aletheia University；Independent Director of E.SUN Bank(China) and Independent Director of Union Commercial Bank PLC.(Cambodia). With strong expertise in international financial supervision and corporate governance.

Director of E.Sun Financial Holdings Co., Ltd. Has over 25 years of experience in the financial industry, with deep expertise in operations, risk management, and corporate governance.